Creon 10000 Gastro-resistant Capsules
- Name:
Creon 10000 Gastro-resistant Capsules
- Company:
Mylan IRE Healthcare Limited
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may be renewed (B)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 17/02/20
(Click to Download)Click on this link to Download PDF directly
Mylan IRE Healthcare Limited
Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 17 February 2020 PIL
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 30 August 2019 PIL
Reasons for updating
- Change to section 5 - how to store or dispose
- Change to section 6 - date of revision
Updated on 30 August 2019 SPC
Reasons for updating
- Change to section 6.3 - Shelf life
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 5 July 2017 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 5 July 2017 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
7. MARKETING AUTHORISATION HOLDER
Mylan IRE Healthcare Limited
Unit 35/36
Grange Parade
Baldoyle Industrial Estate
Dublin 13
Ireland
BGP Products Ireland Limited
4051 Kingswood Drive,
Citywest Business Campus,
Dublin 24
8. MARKETING AUTHORISATION NUMBER
PA 2010/8/1 2007/3/1
10. DATE OF REVISION OF THE TEXT
June 2017
Updated on 30 June 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 30 June 2017 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - marketing authorisation number
- Change to section 6 - date of revision
Updated on 26 June 2017 SPC
Reasons for updating
- Change to section 6.3 - Shelf life
- Change to section 6.4 - Special precautions for storage
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
6.4: The following statement was added to the storage condition: "Keep container tightly closed in order to protect from moisture."
Updated on 22 June 2017 PIL
Reasons for updating
- Change to section 5 - how to store or dispose
Updated on 12 April 2017 SPC
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.6 - Pregnancy and lactation
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
An update to SPC section 4.2 to clarify Creon should be taken ‘during or immediately after’ a meal
and section 4.6 to state that Creon can be prescribed to pregnant women and can be used during breast-feeding
Updated on 10 April 2017 PIL
Reasons for updating
- Change to Section 1 - what the product is
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 3 - dose and frequency
Updated on 22 September 2016 PIL
Reasons for updating
- Change to date of revision
- Change of distributor details
Updated on 26 April 2016 SPC
Reasons for updating
- Change to section 4.1 - Therapeutic indications
- Change to section 5.1 - Pharmacodynamic properties
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Section 5.1: Addition of text: “Treatment with Creon improves the symptoms of pancreatic exocrine insufficiency including stool consistency, abdominal pain, flatulence and stool frequency, independent of the underlying disease.”
Updated on 9 April 2015 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - MA number
- Change to section 10 - Date of revision of the text
- Change to marketing authorisation holder
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 9 April 2015 PIL
Reasons for updating
- Change to further information section
- Change to date of revision
- Change to marketing authorisation holder
Updated on 5 January 2015 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
4.4 Special Warning and Precautions
The warning on the theoretical risk for transmission of viral disease is removed fro.
4.8 Undesirable effects
Include details of reporting suspected adverse reactions
5.1 Pharmacodynamic properties (Editorial change)
Updated on 22 December 2014 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to side-effects
- Change to date of revision
Updated on 11 September 2014 SPC
Reasons for updating
- Change to MA holder contact details
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 4 September 2014 PIL
Reasons for updating
- Change to further information section
- Change to MA holder contact details
Updated on 6 August 2013 PIL
Reasons for updating
- Correction of spelling/typing errors
Updated on 6 August 2013 SPC
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.7 - Effects on ability to drive and use machines
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 4.9 - Overdose
- Change to section 5.1 - Pharmacodynamic properties
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Section 2 - Addition of 'Produced from porcine pancreatic tissue'
Section 4.2 - Changes to text regarding method of administration
Section 4.3 - Update in line with QRD template
Section 4.4 - Extensive updates throughout the section
Section 4.5 - Rewording of this section
Section 4.7 - Rewording of this section
Section 4.8 - Extensive updates throughout the section and addition of adverse events table
Section 4.9 - Changes to text regarding overdose
Section 5.1 - Extensive updates throughout the section
Updated on 1 August 2013 PIL
Reasons for updating
- New PIL for medicines.ie
Updated on 1 October 2012 SPC
Reasons for updating
- Change to section 6.3 - Shelf life
- Change to section 6.4 - Special precautions for storage
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Section 6.4:
Do not store above
Updated on 14 July 2011 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 3 September 2009 SPC
Reasons for updating
- Change to section 6.1 - List of excipients
- Change to section 6.4 - Special precautions for storage
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Following approval of the DBP free formulation the following sections of the SPC have been changed;
In section 6.1 the excipient dibutylphthalate and liquid paraffin have been removed and replaced with cetyl alcohol and triethyl citrate.
In section 6.4 storage conditions have been changed from 25 to 30 degrees C.
Updated on 27 August 2008 SPC
Reasons for updating
- Change to section 3 - Pharmaceutical form
- Change to section 9 - Date of renewal of authorisation
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
section 3 : Capsules, hard changed to
21 March 1997/21 March 2002 changes to
Date of first authorisation: 21st March 1997
Date of last renewal: 21st March 2007
Updated on 28 August 2007 SPC
Reasons for updating
- Change to section 6.1 - List of excipients
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
6.1. List of Excipients
Capsule shell: Gelatin, red, yellow and black iron oxides (E172), titanium dioxide (E171), sodium lauryl sulphate.
6.5. Nature and Contents of Containers
HDPE container with polypropylene cap. Containers hold 100, 250 or 300 capsules.
10. DATE OF REVISION OF THE TEXT
March 2007
Updated on 19 August 2005 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 23 May 2005 SPC
Reasons for updating
- Change to section 4.6 - Pregnancy and lactation
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 11 March 2005 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 5 May 2004 SPC
Reasons for updating
- Change to section 4.6 - Pregnancy and lactation
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 27 June 2003 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)